Single early instillation of mitomycin C and urinary alkalinization in low-risk non-muscle-invasive bladder cancer: a preliminary study

References

• Fitzpatrick JM West AB Butler MR Lane V O’Flynn JD Superficial bladder tumors (stage pTa, grades 1 and 2): the importance of recurrence pattern following initial resection J Urol 1986 135 920 922 3959241
   PubMed Web of Science ®Google Scholar
• Schrier BP Hollander MP van Rhijn BW Kiemeney LA Witjes JA Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy Eur Urol 2004 45 292 296 15036673
   PubMed Web of Science ®Google Scholar
• Bouffioux C Kurth KH Bono A Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of 2 European Organization for Research and Treatment of Cancer randomized trials with mitomycin C and doxorubicin comparing early versus delayed instillations and short-term versus long-term treatment. European Organization for Research and Treatment of Cancer Genitourinary Group J Urol 1995 153 934 941 7853578
   PubMed Web of Science ®Google Scholar
• Soloway MS Masters S Urothelial susceptibility to tumor cell implantation: influence of catheterization Cancer 1980 46 1158 1163 7214299
   PubMed Web of Science ®Google Scholar
• Pan JS Slocum HK Rustum YM Greco WR Gaeta JF Huben RP Inhibition of implantation of murine bladder tumor by thiotepa in cauterized bladder J Urol 1989 142 1589 1593 2511340
   PubMed Web of Science ®Google Scholar
• Pode D Alon Y Horowitz AT Vlodavsky I Biran S The mechanism of human bladder tumor implantation in an in vitro model J Urol 1986 136 482 486 3525861
   PubMed Web of Science ®Google Scholar
• Türkeri L Yüzeyel mesane kanserinin tedavisinde postoperatif erken dönemde tek doz intravezikal kemoterapinin yeri The role of a single dose intravesical chemotherapy in early postoperative period in the treatment of superficial bladder cancer Üroonkoloji Bülteni 2003 1 14 17 Turkish
   Google Scholar
• Burnand KG Boyd PJ Mayo ME Shuttleworth KE Lloyd-Davies RW Single dose intravesical thiotepa as an adjuvant to cystodiathermy in the treatment of transitional cell bladder carcinoma Br J Urol 1976 48 55 59 817761
   PubMedGoogle Scholar
• Abrams PH Choa RG Gaches CG Ashken MH Green NA A controlled trial of single dose intravesical adriamycin in superficial bladder tumours Br J Urol 1981 53 585 587 7032640
   PubMedGoogle Scholar
• Zincke H Utz DC Taylor WF Myers RP Leary FJ Influence of thiotepa and doxorubicin instillation at time of transurethral surgical treatment of bladder cancer on tumor recurrence: a prospective, randomized, double-blind, controlled trial J Urol 1983 129 505 509 6403716
   PubMed Web of Science ®Google Scholar
• Oosterlinck W Kurth KH Schröder F Bultinck J Hammond B Sylvester R A prospective European Organization for Research and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta, T1 papillary carcinoma of the bladder J Urol 1993 149 749 752 8455236
   PubMed Web of Science ®Google Scholar
• Tolley DA Parmar MK Grigor KM The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up J Urol 1996 155 1233 1238 8632538
   PubMed Web of Science ®Google Scholar
• Ali-el-Dein B Nabeeh A el-Baz M Shamaa S Ashamallah A Single-dose versus multiple instillations of epirubicin as prophylaxis for recurrence after transurethral resection of pTa and pT1 transitional-cell bladder tumours: a prospective, randomized controlled study Br J Urol 1997 79 731 735 9158511
   PubMedGoogle Scholar
• Solsona E Iborra I Ricós JV Monrós JL Casanova J Dumont R Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term followup J Urol 1999 161 1120 1123 10081851
   PubMed Web of Science ®Google Scholar
• Rajala P Kaasinen E Raitanen M Liukkonen T Rintala E Finnbladder Group Perioperative single dose instillation of epirubicin or interferon-alpha after transurethral resection for the prophylaxis of primary superficial bladder cancer recurrence: a prospective randomized multicenter study – FinnBladder III long-term results J Urol 2002 168 981 985 12187204
   PubMed Web of Science ®Google Scholar
• Okamura K Ono Y Kinukawa T Nagoya University Urological Oncology Group Randomized study of single early instillation of (2″R)-4′-O-tetrahydropyranyl-doxorubicin for a single superficial bladder carcinoma Cancer 2002 94 2363 2368 12015761
   PubMed Web of Science ®Google Scholar
• Sylvester RJ Oosterlinck W van der Meijden AP A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials J Urol 2004 171 2186 2190 15126782
   PubMed Web of Science ®Google Scholar
• Babjuk M Oosterlinck W Sylvester R Kaasinen E Böhle A Palou-Redorta J European Association of Urology (EAU) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder Eur Urol 2008 54 303 314 18468779
   PubMed Web of Science ®Google Scholar
• Au JL Badalament RA Wientjes MG International Mitomycin C Consortium Methods to improve efficacy of intravesical mitomycin C: results of a randomized Phase III trial J Natl Cancer Inst 2001 93 597 604 11309436
   PubMed Web of Science ®Google Scholar
• Dalton JT Wientjes MG Badalament RA Drago JR Au JL Pharmacokinetics of intravesical mitomycin C in superficial bladder cancer patients Cancer Res 1991 51 5144 5152 1913640
   PubMed Web of Science ®Google Scholar
• Kuroda M Nijima T Kotake T Akaza H Hinotsu S 6th Trial of the Japanese Urological Cancer Research Group Effect of prophylactic treatment with intravesical epirubicin on recurrence of superficial bladder cancer – The 6th Trial of the Japanese Urological Cancer Research Group (JUCRG): a randomized trial of intravesical epirubicin at dose of 20 mg/40 mL, 30 mg/40 mL, 40 mg/40 mL Eur Urol 2004 45 600 605 15082202
   PubMed Web of Science ®Google Scholar
• Maeda T Kikuchi E Matsumoto K Miyajima A Oya M Urinary pH is highly associated with tumor recurrence during intravesical mitomycin C therapy for nonmuscle invasive bladder tumor J Urol 2011 185 802 806 21239010
   PubMed Web of Science ®Google Scholar
• Groos E Walker L Masters JR Intravesical chemotherapy. Studies on the relationship between pH and cytotoxicity Cancer 1986 58 1199 1203 3091241
   PubMed Web of Science ®Google Scholar
• Yen WC Schmittgen T Au JL Different pH dependency of mitomycin C activity in monolayer and three-dimensional cultures Pharm Res 1996 13 1887 1891 8987090
   PubMed Web of Science ®Google Scholar